Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

20.18

+1.85 (10.09%)

At close: May 12, 2025, 4:00 PM

21.00

+0.82 (4.06%)

After-hours: May 12, 2025, 6:57 PM EDT

Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $1.34 billion as of May 12, 2025. Its market cap has decreased by -35.25% in one year.

Market Cap

1.34B

Enterprise Value

669.97M

1-Year Change

-35.25%

Ranking

#2239

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $1.34B, an increase of 804.68%. That is a compound annual growth rate of 10.63%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	1.22B	-27.41%
Dec 31, 2024	1.68B	-10.56%
Dec 29, 2023	1.87B	-10.70%
Dec 30, 2022	2.10B	16.42%
Dec 31, 2021	1.80B	160.11%
Dec 31, 2020	693.20M	1,825.56%
Dec 31, 2019	36.00M	5.57%
Dec 31, 2018	34.10M	-91.17%
Dec 29, 2017	386.20M	7.76%
Dec 30, 2016	358.40M	-76.83%
Dec 31, 2015	1.55B	-5.39%
Dec 31, 2014	1.64B	-16.73%
Dec 31, 2013	1.96B	372.13%
Dec 31, 2012	415.90M	262.28%
Dec 30, 2011	114.80M	-13.10%
Dec 31, 2010	132.10M	-10.50%
Dec 31, 2009	147.60M	17.99%
Dec 31, 2008	125.10M	237.20%
Dec 31, 2007	37.10M	-62.68%
Dec 29, 2006	99.40M	-28.69%
Dec 30, 2005	139.40M	-6.44%
Dec 31, 2004	149.00M	-15.96%
Dec 31, 2003	177.30M	19.72%

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	678.30B
Johnson & Johnson	370.87B
UnitedHealth Group	343.58B
AbbVie	335.74B
Novo Nordisk	292.03B
Abbott Laboratories	229.64B
Novartis AG	213.30B
AstraZeneca	210.42B

Market Cap Rankings